Network analysis of genomic alteration profiles reveals co-altered functional modules and driver genes for

Yunyan Gu1, Hongwei Wang, Yao Qin

  • 1College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150086, China. guyunyan@ems.hrbmu.edu.cn

Molecular Biosystems
|January 25, 2013
PubMed

Insights

This study introduces a network-based method to uncover cooperative gene modules in glioblastoma (GBM) by analyzing genetic alterations. It reveals significant co-altered pathways, offering new insights into cancer mechanisms and therapeutic strategies.

Area of Science:

  • Genomics
  • Cancer Biology
  • Bioinformatics

Background:

  • Genetic alterations in human cancer genomes are highly heterogeneous, complicating cancer mechanism understanding and driver gene identification.
  • Existing pathway-level approaches often overlook inter-pathway correlations and genes with rare, collective contributions to carcinogenesis.

Purpose of the Study:

  • To develop a network-based approach for identifying cooperative functional modules in glioblastoma (GBM) by analyzing genome-wide genetic alterations.
  • To capture the non-random correlations between gene alterations across pathways.

Main Methods:

  • Utilized genome-wide somatic mutation and copy number alteration data from The Cancer Genome Atlas (TCGA) for glioblastoma.
  • Employed a network-based approach to define and identify cooperative functional modules based on dense interactions within protein-protein interaction networks.
  • Analyzed co-alteration patterns among identified modules.

Main Results:

  • Identified 7 pairs of significantly co-altered modules in GBM, involving key signaling pathways like TP53, RB, and RTK.
  • Highlighted striking co-occurring alterations within these GBM pathways.
  • Demonstrated that co-alteration properties can distinguish oncogenic modules containing GBM driver genes.

Conclusions:

  • The collaboration among cancer pathways provides a new perspective on carcinogenesis mechanisms, including redundant and aggravating models.
  • Findings offer novel indications for designing targeted cancer therapeutic strategies for glioblastoma.

Related Concept Videos